Use of colloids of chromic [32P] phosphate in treatment of solid tumors.

[1]  M. Zubillaga,et al.  Great particles [32P]chromic phosphate for treatment of solid tumors. , 1996, Acta physiologica, pharmacologica et therapeutica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia.

[2]  J. Blasko,et al.  Brachytherapy for prostate cancer , 1995, CA: a cancer journal for clinicians.

[3]  D. Kondziolka,et al.  Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. , 1995, Journal of neurosurgery.

[4]  C. Davio,et al.  Induction of mammary tumors in rat by intraperitoneal injection of NMU: histopathology and estral cycle influence. , 1994, Cancer letters.

[5]  B. Jose,et al.  Use of P-32 in stage III epithelial carcinoma of the ovary. , 1994, Gynecologic oncology.

[6]  G. Rivard,et al.  Synoviorthesis with colloidal 32P chromic phosphate for the treatment of hemophilic arthropathy. , 1994, The Journal of bone and joint surgery. American volume.

[7]  J. Luck,et al.  Hemarthrosis and synovitis associated with hemophilia: clinical use of P-32 chromic phosphate synoviorthesis for treatment. , 1994, Radiology.

[8]  M. G. Brizi,et al.  [Diagnostic and therapeutic integration in ductal carcinoma of the head of the pancreas. Preliminary note]. , 1993, La Radiologia medica.

[9]  D. Beyer,et al.  Guided brachytherapy for treatment of confined prostate cancer. , 1992, Urology.

[10]  A. Berchuck,et al.  Adjuvant Therapy With Intraperitoneal Chromic Phosphate (32P) in Women With Early Ovarian Carcinoma After Comprehensive Surgical Staging , 1992, Obstetrics and gynecology.

[11]  Z. Tian [Stereotactic intracavitary irradiation of huge cystic craniopharyngiomas]. , 1992, Zhonghua wai ke za zhi [Chinese journal of surgery].

[12]  Tian Zengmin,et al.  CT-Guided Stereotactic Injection of Radionuclide for Treatment of Brain Tumors , 1992 .

[13]  L. Fig,et al.  Distribution of [32P]-chromic phosphate colloid in cystic brain tumors. , 1992, Stereotactic and functional neurosurgery.

[14]  S. Houle,et al.  Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. , 1989, Radiology.

[15]  S. Loening,et al.  Percutaneous transperineal placement of gold 198 seeds for treatment of carcinoma of the prostate , 1988, The Prostate.

[16]  S. Strand,et al.  The "critical colloid dose" in studies of reticuloendothelial function. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  P. Gullino,et al.  N-nitrosomethylurea as mammary gland carcinogen in rats. , 1975, Journal of the National Cancer Institute.

[18]  G. Czapski RADIATION CHEMISTRY OF OXYGENATED AQUEOUS SOLUTIONS. , 1971 .

[19]  R. Caro,et al.  Kinetics of the disappearance of gelatin protected radiogold colloids from the blood stream. , 1968, The International journal of applied radiation and isotopes.

[20]  E. B. Doğan,et al.  Prevention of abdominal metastases after intraperitoneal injection of Yoshida ascites cells: use of a new colloidal 32P-chromic phosphate. , 1968, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  L. Anghileri,et al.  New colloidal chromic radiophosphate (P32) for local irradiation of the central nervous system. , 1967, The International journal of applied radiation and isotopes.